Simple Summary Significant gender disparities have been highlighted in the incidence,
aggressiveness, and prognosis of HCC. A different epidemiological distribution of the risk …

Simple Summary The treatment of hepatocellular carcinoma is burdened by an
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …

Background We sought to examine the prognostic impact of margin width at time of
hepatocellular carcinoma (HCC) resection relative to the alpha-feto protein tumor burden …

Objective: This study aimed to investigate the role of squamous cell carcinoma antigen
recognized by T cells 3 (SART3) in hepatocellular carcinoma (HCC). Methods: SART3 …

Background This study aimed to establish a simple prognostic scoring model based on
tumor burden score (TBS) and PIVKA‐II to predict long‐term outcomes of α‐fetoprotein …

Background This study aimed to examine glycolysis/gluconeogenesis-related genes in
hepatocellular carcinoma (HCC) and evaluate their potential roles in HCC progression and …

Objective This study aims to identify independent risk factors for ultra-early recurrence in
patients with early solitary hepatocellular carcinoma (HCC) and develop an individualized …

Abstract Approximately 50%-70% of patients with hepatocellular carcinoma experience
recurrence within five years after curative hepatic resection or ablation. As a result, many …

Background Previous studies indicate that the splicing process, regulated by the cellular
machinery of tumors (spliceosome), undergoes alterations, leading to oncogenic splicing …

Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and a significant global
health burden, with increasing incidence rates and limited treatment options …